Tag: Kinoxis Therapeutics
University of Sydney spinout bags $273m for psychiatric drug dev’t
Kinoxis Therapeutics, a University of Sydney spinoff, announced a partnership with German pharmaceutical company Boehringer Ingelheim to develop precision therapies that target oxytocin aimed at enhancing the quality of life for people with psychiatric disorders.
Featured Article
The future of steel engineering: Using CRM systems across supply chains
The construction industry has undergone significant transformation over the past twenty years. Speedpanel, a leading Australian manufacturer of lightweight, fire-rated, and acoustic wall systems, made a groundbreaking entrance in the early '90s, revolutionising the Australian construction landscape.
